***ESCOM*** ESCORT TEKNOLOJİ YATIRIM A.Ş.( Material Disclosure (General) )
Related companies 
Related Funds 
Disclosure of exceptions (public)
Is the statement an update?
Is the explanation correct?
Date of previous statement on the subject
Is the disclosure deferred disclosure?
Content of notices
We participated in Glaucot Teknoloji Anonim Şirketi (www.glaucot.com), which aims to stop Glaucom disease, which causes blindness at an advanced stage, without surgery or medication, with the patented technology she developed, for a share of 3,334% on a valuation of 12,705,000 TL, and we announced this in our PDP statement of 20.09.2021.
Glaucot, which is still continuing its clinical studies with the approval of the Turkish Medicines and Medical Devices Agency for the certification of the portable medical device it has developed, this time received a new investment with a valuation of 44,370,000 TL, and our company will increase its share to 5.97% with an additional cost of 1,220,175 TL participated in the investment round.
Glaucot aims to use its new investment for patent applications for glasses it developed to measure eye pressure at home without going to the hospital, and to fund ongoing clinical studies.
We present it to the public.